Summary:
- A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
- MACD is crossing MACD signal line at 0.5. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Anthem, Inc. (NYSE: ANTM) will release fourth quarter 2020 financial results on January 27, 2021, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
The telehealth sector seems poised to maintain its robust growth in the future owing to the convenience it provides, making it a good time to keep an eye on names like Teladoc Health (TDOC) and Anthem (ANTM)
4 HMO Stocks in Focus as Players Adapt to Changes in the Industry
Anthem (ANTM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna's (CI) sale of its non-health unit paves way for it to focus on its core business and make debt repayments.
Riding high on strategic initiatives and growing membership, Anthem (ANTM) holds potential to reap benefits for investors.
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Anthem (ANTM) closed at $308.64 in the latest trading session, marking a -1.73% move from the prior day.
Anthem, Inc. (NYSE: ANTM) announced today Dr. Shantanu Agrawal has been named Chief Health Officer, effective January 25, 2020. Dr. Agrawal will oversee Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s industry-leading work to address the social drivers of health. He will also lead Anthem’s community health strategy and the Anthem Foundation. He will report directly to Gail K. Boudreaux, President and Chief Executive Officer, Anthem.